Genome-wide association study with DNA pooling identifies variants at CNTNAP2 associated with pseudoexfoliation syndrome

European Journal of Human Genetics

Volumn 19, Issue 2, 2011, Pages 186-193

  Krumbiegel, Mandy ^a   Pasutto, Francesca ^a   Schlötzer Schrehardt, Ursula ^a   Uebe, Steffen ^a   Zenkel, Matthias ^a   Mardin, Christian Y ^a   Weisschuh, Nicole ^b   Paoli, Daniela ^c   Gramer, Eugen ^d   Becker, Christian ^e   Ekici, Arif B ^a   Weber, Bernhard H F ^f   Nürnberg, Peter ^e   Kruse, Friedrich E ^a   Reis, André ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Hospital of Monfalcone   (Italy)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

association study; DNA pooling; pseudoexfoliation syndrome

Indexed keywords

DNA; LYSYL OXIDASE LIKE 1 PROTEIN; PROTEIN LYSINE 6 OXIDASE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CELL MEMBRANE; COHORT ANALYSIS; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA REPLICATION; ENDOTHELIUM CELL; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE POOL; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERMANY; GLAUCOMA; GLIA CELL; HUMAN; HUMAN TISSUE; ITALY; LOXL1 GENE; MAJOR CLINICAL STUDY; MALE; NERVE CELL; POPULATION GENETICS; PRIORITY JOURNAL; PSEUDOEXFOLIATION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXFOLIATION SYNDROME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SOFTWARE;

EID: 78651392567     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.144     Document Type: Article

References (47)

1. Schlotzer-Schrehardt U, Naumann GO: Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006; 141: 921-937.
2. Ritch R, Schlotzer-Schrehardt U: Exfoliation syndrome. Surv Ophthalmol 2001; 45: 265-315. (Pubitemid 32146432)
3. Damji KF, Bains HS, Stefansson E et al: Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genet 1998; 19: 175-185.
4. Orr AC, Robitaille JM, Price PA et al: Exfoliation syndrome: clinical and genetic features. Ophthalmic Genet 2001; 22: 171-185.
5. Ovodenko B, Rostagno A, Neubert TA et al: Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci 2007; 48: 1447-1457.
6. Sharma S, Chataway T, Burdon KP et al: Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry. Exp Eye Res 2009; 89: 479-485.
7. Burdon KP, Sharma S, Hewitt AW et al: Genetic analysis of the clusterin gene in pseudoexfoliation syndrome. Mol Vis 2008; 14: 1727-1736.
8. Krumbiegel M, Pasutto F, Mardin CY et al: Exploring functional candidate genes for genetic association in german patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 2009; 50: 2796-2801.
9. Ritland JS, Utheim TP, Utheim OA et al: Effects of APOE and CHRNA4 genotypes on retinal nerve fibre layer thickness at the optic disc and on risk for developing exfoliation syndrome. Acta Ophthalmol Scand 2007; 85: 257-261.
10. Yilmaz A, Tamer L, Ates NA, Camdeviren H, Degirmenci U: Effects of apolipoprotein E genotypes on the development of exfoliation syndrome. Exp Eye Res 2005; 80: 871-875.
11. Krumbiegel M, Pasutto F, Mardin CY et al: Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Glaucoma, In press.
12. Thorleifsson G, Magnusson KP, Sulem P et al: Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007; 317: 1397-1400.
13. Fan BJ, Pasquale L, Grosskreutz CL et al: DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a US clinic-based population with broad ethnic diversity. BMC Med Genet 2008; 9: 5.
14. Challa P, Schmidt S, Liu Y et al: Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Mol Vis 2008; 14: 146-149.
15. Ramprasad VL, George R, Soumittra N, Sharmila F, Vijaya L, Kumaramanickavel G: Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India. Mol Vis 2008; 14: 318-322.
16. Aragon-Martin JA, Ritch R, Liebmann J et al: Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Mol Vis 2008; 14: 533-541.
17. Mossbock G, Renner W, Faschinger C, Schmut O, Wedrich A, Weger M: Lysyl oxidaselike protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population. Mol Vis 2008; 14: 857-861.
18. Mori K, Imai K, Matsuda A et al: LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population. Mol Vis 2008; 14: 1037-1040.
19. Fuse N, Miyazawa A, Nakazawa T, Mengkegale M, Otomo T, Nishida K: Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese. Mol Vis 2008; 14: 1338-1343.
20. Gong WF, Chiang SW, Chen LJ et al: Evaluation of LOXL1 polymorphisms in primary open-angle glaucoma in southern and northern Chinese. Mol Vis 2008; 14: 2381-2389.
21. Hayashi H, Gotoh N, Ueda Y, Nakanishi H, Yoshimura N: Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. Am J Ophthalmol 2008; 145: 582-585.
22. Lemmela S, Forsman E, Onkamo P et al: Association of LOXL1 gene with Finnish exfoliation syndrome patients. J Hum Genet 2009; 54: 289-297.
23. Pasutto F, Krumbiegel M, Mardin CY et al: Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 2008; 49: 1459-1463.
24. Macgregor S, Zhao ZZ, Henders A, Nicholas MG, Montgomery GW, Visscher PM: Highly cost-efficient genome-wide association studies using DNA pools and dense SNP arrays. Nucleic Acids Res 2008; 36: e35.
25. Craig JE, Hewitt AW, McMellon AE et al: Rapid inexpensive genome-wide association using pooled whole blood. Genome Res 2009; 19: 2075-2080.
26. Johnson C, Drgon T, Liu QR et al: Pooled association genome scanning for alcohol dependence using 104 268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 844-853.
27. Butcher LM, Meaburn E, Dale PS et al: Association analysis of mild mental impairment using DNA pooling to screen 432 brain-expressed single-nucleotide polymorphisms. Mol Psychiatry 2005; 10: 384-392.
28. Butcher LM, Davis OS, Craig IW, Plomin R: Genome-wide quantitative trait locus association scan of general cognitive ability using pooled DNA and 500K single nucleotide polymorphism microarrays. Genes Brain Behav 2008; 7: 435-446. (Pubitemid 351590930)
29. Comabella M, Craig DW, Camina-Tato M et al: Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 2008; 3: e3490.
30. Hinds DA, Seymour AB, Durham LK et al: Application of pooled genotyping to scan candidate regions for association with HDL cholesterol levels. Hum Genomics 2004; 1: 421-434.
31. Pearson JV, Huentelman MJ, Halperin RF et al: Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. Am J Hum Genet 2007; 80: 126-139.
32. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
33. Schlotzer-Schrehardt U, Pasutto F, Sommer P et al: Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/ glaucoma and normal patients. Am J Pathol 2008; 173: 1724-1735.
34. Zenkel M, Kruse FE, Junemann AG, Naumann GO, Schlotzer-Schrehardt U: Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest Ophthalmol Vis Sci 2006; 47: 1982-1990.
35. Schlotzer-Schrehardt U, Zenkel M, Nusing RM: Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest Ophthalmol Vis Sci 2002; 43: 1475-1487.
36. Poliak S, Gollan L, Martinez R et al: Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 1999; 24: 1037-1047.
37. Einheber S, Zanazzi G, Ching W et al: The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 1997; 139: 1495-1506.
38. Horresh I, Poliak S, Grant S, Bredt D, Rasband MN, Peles E: Multiple molecular interactions determine the clustering of Caspr2 and Kv1 channels in myelinated axons. J Neurosci 2008; 28: 14213-14222.
39. Verkerk AJ, Mathews CA, Joosse M, Eussen BH, Heutink P, Oostra BA: CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003; 82: 1-9.
40. Friedman JI, Vrijenhoek T, Markx S et al: CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2008; 13: 261-266.
41. Alarcon M, Abrahams BS, Stone JL et al: Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008; 82: 150-159.
42. Arking DE, Cutler DJ, Brune CW et al: A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008; 82: 160-164.
43. Bakkaloglu B, O'Roak BJ, Louvi A et al: Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 2008; 82: 165-173.
44. Strauss KA, Puffenberger EG, HuentelmanMJ et al: Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med 2006; 354: 1370-1377.
45. Zweier C, de Jong EK, Zweier M et al: CNTNAP2 and NRXN1 are mutated in autosomalrecessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 2009; 85: 655-666.
46. Nakayama M, Nakajima D, Nagase T, Nomura N, Seki N, Ohara O: Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening. Genomics 1998; 51: 27-34.
47. Brown AA, Xu T, Arroyo EJ et al: Molecular organization of the nodal region is not altered in spontaneously diabetic BB-Wistar rats. J Neurosci Res 2001; 65: 139-149.